Effects of acute and chronic administration of the serotonin(1A) agonist buspirone on serotonin synthesis in the rat brain

Journal of Neurochemistry

Volumn 72, Issue 5, 1999, Pages 2022-2031

  Okazawa, Hidehiko ^b   Yamane, Fumitaka ^b   Blier, Pierre ^a   Diksic, Mirko ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Methyl L tryptophan; Autoradiography; Buspirone; Serotonin synthesis rate

Indexed keywords

BUSPIRONE; N METHYLTRYPTOPHAN; PINDOLOL; SEROTONIN 1A AGONIST;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN CELL; CONTROLLED STUDY; MALE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; SEROTONIN RELEASE; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE DISTRIBUTION; TRYPTOPHAN BRAIN LEVEL;

ANIMALS; AUTORADIOGRAPHY; BRAIN; BUSPIRONE; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGONISTS; TIME FACTORS; TRYPTOPHAN;

ANIMALIA;

EID: 0033005084     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0722022.x     Document Type: Article

References (51)

1. 1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1, 470-480.
2. 1 receptor agonists and p-chloroamphetamine. Synapse 5, 120-133.
3. Blier P., Piñeyro G., Dennis T., and de Montigny C. (1993) Electrophysiology of central serotonin neurotransmission, in Serotonin (Paoletti R., Vanhoutte P. M., and Saxena P. R., eds), pp. 55-63. Kluwer Academic, Amsterdam.
4. Bloxam D. L. and Curzon G. (1978) A study of proposed determinants of brain tryptophan concentration in rats after portocaval anastomosis or sham operation. J. Neurochem. 31, 1255-1263.
5. 1A receptors mediate 5-hydroxytryptamine release in the amygdala through a feedback to the caudal linear raphe. Eur. J. Pharmacol. 333, 147-157.
6. Ceci A., Baschirotto A., and Borsini F. (1994) The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex. Neuropharmacology 33, 709-713.
7. Cohen Z., Tsuiki K., Takada A., Beaudet A., Diksic M., and Hamel E. (1995) In vivo-synthesized radioactively labeled α-methyl serotonin as a selective tracer for visualization of brain serotonin neurons. Synapse 21, 21-28.
8. De Simoni M. G., Imeri L., Luigi A. D., Fodritto F., and Garattini S. (1990) Effect of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine on hippocampal serotonergic system, studied in freely moving rats. Life Sci. 46, 197-205.
9. Diksic M., Nagahiro S., Sourkes T. L., and Yamamoto Y. L. (1990) A new method to measure brain serotonin synthesis in vivo. I. Theory and basic data for a biological model. J. Cereb. Blood Flow Metab. 10, 1-12.
10. Diksic M., Nagahiro S., Chaly T., Sourkes T. L., Yamamoto Y. L., and Feindel W. (1991) Serotonin synthesis rate measured in living dog brain by positron emission tomography. J. Neurochem. 56, 153-162.
11. 1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe. Naunyn Schmiedebergs Arch. Pharmacol. 356, 303-311.
12. Feighner J. P., Merideth C. H., and Hendrickson G. A. (1982) A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder. J. Clin. Psychiatry 43 (Sect. 2), 103-107.
13. Freo U., Pietrini P., Pizzolato G., Furey-Kurjian M., Merico A., Ruggero S., Dam M., and Battistin L. (1995) Dose-dependent effects of buspirone on behavior and cerebral glucose metabolism in rats. Brain Res. 677, 213-220.
14. Godbout R., Chaput Y., Blier P., and de Montigny C. (1991) Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine: I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission. Neuropharmacology 30, 679-690.
15. Goldberg H. L. and Finnerty R. J. (1979) The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am. J. Psychiatry 136, 1184-1187.
16. Goldberg H. L. and Finnerty R. (1982) Comparison of buspirone in two separate studies. J. Clin. Psychiatry 43 (Sect. 2), 87-91.
17. 1A receptors. J. Neurosci. 18, 10150-10156.
18. Hjorth S. and Carlsson A. (1982) Buspirone: effects on central monoaminergic transmission - possible relevance to animal experimental and clinical findings. Eur. J. Pharmacol. 83, 299-303.
19. 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 338, 463-471.
20. Hutson P. H., Sarna G. S., O'Connell M. T., and Curzon G. (1989) Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Neurosci. Lett. 100, 276-280.
21. Invernizzi R., Carli M., Di Clemente A., and Samanin R. (1991) Administration of 8-hydroxy-2-(di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity. J. Neurochem. 56, 243-247.
22. Jacobson A. F., Dominguez R. A., Goldstein B. J., and Steinbook R. M. (1985) Comparison of buspirone and diazepam in generalized anxiety disorder. Pharmacotherapy 5, 290-296.
23. 1A agonists and conventional antidepressants in an animal model of depression. Eur. J. Pharmacol. 134, 265-274.
24. 1A receptor-mediated effects of buspirone, gepirone and ipsapirone. Pharmacol. Biochem. Behav. 29, 711-715.
25. 1A autoreceptors of the dorsal and median raphe nuclei. Synapse 25, 107-116.
26. 1A receptor agonist 8-OH-DPAT. Neuropharmacology 29, 85-91.
27. Molliver M. E. (1987) Serotonergic neuronal systems: what their anatomic organization tells us about function. J. Clin. Psychopharmacol. 7 (Suppl.), 3S-23S.
28. Mück-Šeler D. and Diksic M. (1995) The acute effects of reserpine and NSD-1015 on the brain serotonin synthesis rate measured by an autoradiographic method. Neuropsychopharmacology 12, 251-262.
29. Mück-Šeler D. and Diksic M. (1996) DL-Fenfluramine increases the 5-HT synthesis rate in the terminals while decreasing it in the cell bodies of the rat brain. Brain Res. 737, 45-50.
30. Mück-Šeler D. and Diksic M. (1997) Serotonin synthesis increased in terminals four days after reserpine treatment - an autoradiographic study in rat brain. Neurochem. Res. 22, 11-16.
31. Mück-Šeler D., Jevric-Causevic A., and Diksic M. (1996) Influence of fluoxetine on regional serotonin synthesis in the rat brain. J. Neurochem. 67, 2434-2442.
32. 14C]methyl-L-tryptophan. Appl. Radiat. Isot. 44, 1167-1172.
33. Nagahiro S., Takada A., Diksic M., Sourkes T. L., Missala K., and Yamamoto Y. L. (1990) A new method to measure brain serotonin synthesis in vivo. II. A practical autoradiographic method tested in normal and lithium-treated rats. J. Cereb. Blood Flow Metab. 10, 13-21.
34. Patlak C. S., Blasberg R. G., and Fenstermacher J. D. (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3, 1-7.
35. Pazos A. and Palacios J. M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346, 205-230.
36. 1B binding sites in bovine brain. Brain Res. 344, 167-171.
37. 1A receptors. Biol. Psychiatry 20, 971-979.
38. Rickels K., Weisman K., Norstad N., Singer M., Stoltz D., Brown A., and Danton J. (1982) Buspirone and diazepam in anxiety: a controlled study. J. Clin. Psychiatry 43 (Sect. 2), 81-86.
39. Salter M., Knowles R. G. and Pogson C. I. (1989) How does displacement of albumin-bound tryptophan cause sustained increases in the free tryptophan concentration in plasma and 5-hydroxytryptamine synthesis in brain? Biochem. J. 262, 365-368.
40. Schlechter L. E., Bolaños F. J., Gozlan H., Lanfumey L., Haj-Dahmane S., Laporte A.-M., Fattaccini C.-M., and Hamon M. (1990) Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies. J. Pharmacol Exp. Ther. 255, 1335-1347.
41. Schweizer E. E., Amsterdam J., Rickels K., Kaplan M., and Droba M. (1986) Open trial of buspirone in the treatment of major depressive disorder. Psychopharmacol. Bull. 22, 183-185.
42. 1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br. J. Pharmacol. 96, 283-290.
43. 1A receptor agonists on 5-HT release in rat brain in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 348, 339-346.
44. 1 receptors. Eur. J. Pharmacol. 157, 173-181.
45. Sourkes T. L. (1971) Alpha-methyltryptophan and its action on tryptophan metabolism. Fed. Proc. 30, 897-903.
46. Tsuiki K., Yamamoto Y. L., and Diksic M. (1995) Effect of acute fluoxetine treatment on the brain serotonin synthesis as measured by the α-methyl-L-tryptophan autoradiographic method. J. Neurochem. 65, 250-256.
47. Tunnicliff G. (1991) Molecular basis of buspirone's anxiolytic action. Pharmacol. Toxicol. 69, 149-156.
48. Tunnicliff G., Brokaw J. J., Hausz J. A., Matheson G. K., and White G. W. (1992) Influence of repeated treatment with buspirone on central 5-hydroxytryptamine and dopamine synthesis. Neuropharmacology 31, 991-995.
49. VanderMaelen C. P., Matheson G. K., Wilderman R. C., and Patterson L. A. (1986) Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur. J. Pharmacol. 129, 123-130.
50. Vanier M., Tsuiki K., Grdiša M., Worsley K., and Diksic M. (1995) Determination of the lumped constant for the α-methyltryptophan method of estimating the rate of serotonin synthesis. J. Neurochem. 64, 624-635.
51. Wu Y. H., Rayburn J. W., Allen L. E., Ferguson H. C., and Kissel J. W. (1972) Psychosedative agents. 2. 8-(4-Substituted 1-piperazinylalkyl)-8-azaspiro(4.5)decane-7,9-diones. J. Med. Chem. 15, 477-479.